Pediapharm Engages Paradox Public Relations Inc.
01 Mai 2014 - 10:30PM
Marketwired
Pediapharm Engages Paradox Public Relations Inc.
MONTREAL, QUEBEC--(Marketwired - May 1, 2014) - Pediapharm Inc.
("Pediapharm" or the "Corporation") (TSX-VENTURE:PDP) is pleased to
announce that it has engaged Paradox Public Relations Inc.
("Paradox") as strategic investor relations consultants to the
Corporation. Paradox will focus on developing and expanding
Pediapharm's communications with the investment community through a
comprehensive investor relations program.
Paradox is an investor relations company founded in 2001 and is
based in Montreal, Canada. Paradox provides a wide range of
services to companies to help broaden investor exposure and develop
a shareholder following.
The term of the agreement entered into between the Corporation
and Paradox is for an initial period of six months. In
consideration for its services, Pediapharm has agreed to pay to
Paradox a monthly fee of $6,800. In addition, the Corporation has
granted to Paradox stock options giving it the right to purchase up
to 100,000 common shares of the Corporation at an exercise price of
$0.36 per common share for a period of one year. The options
granted will vest monthly in 12 equal tranches starting on the
grant date.
About Pedipharm Inc.
Pediapharm is the only Canadian specialty pharmaceutical company
dedicated to serving the needs of the pediatric community. Its
mission is to bring to the Canadian market the latest innovative
pediatric products with the objective to improve the health and the
well-being of children in Canada. Since its debut in 2008,
Pediapharm has entered into numerous commercial agreements with
partners from Canada and other countries around the world. The
company's innovative product portfolio includes NYDA®; a
breakthrough treatment for head lice; EpiCeram® a non-steroid
emulsion for eczema; KoolEffect™ which reduces the symptoms of
fever; and VapoLyptus™; a soothing vapour patch of Eucalyptus and
Camphor.
About Paradox Public Relations Inc.
Paradox Public Relations Inc. was formed in 2001 and is
headquartered in Montreal, Quebec, Canada. Its bilingual (English
and French) team of professionals offers experience and expertise
in investor relations, corporate communications and non-deal road
shows. Paradox specializes in the development and marketing of
emerging growth, micro cap and small cap companies. With over 13
years of continued service, Paradox has developed extensive
national and international contacts including brokers, investment
advisors, institutional investors, investment funds, analysts,
newsletter writers, media and private investors.
Pediapharm Inc.Sylvain ChretienPresident and Chief Executive
Officer+1-514-762-2626 ext.
201sylvain.chretien@pedia-pharm.comRoland BoivinChief Financial
Officer+1-514-762-2626 ext.
202roland.boivin@pedia-pharm.comRelations Publiques Paradox Public
Relations Inc.Carl
Desjardins+1-514-341-0408carldesjardins@paradox-pr.ca
Pediapharm Inc. (TSXV:PDP)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Pediapharm Inc. (TSXV:PDP)
Historical Stock Chart
Von Jun 2023 bis Jun 2024